Insider Selling: Option Care Health, Inc. (NASDAQ:OPCH) Director Sells 1,923 Shares of Stock
Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) Director R Carter Pate sold 1,923 shares of Option Care Health stock in a transaction that occurred on Wednesday, June 1st. The stock was sold at an average price of $30.54, for a total transaction of $58,728.42. Following the sale, the director now owns 107,070 shares in the company, valued at $3,269,917.80. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Shares of NASDAQ:OPCH traded down $0.48 during mid-day trading on Friday, hitting $30.23. The company had a trading volume of 609,350 shares, compared to its average volume of 809,230. The firm has a fifty day moving average price of $28.73 and a 200 day moving average price of $26.59. The company has a market capitalization of $5.44 billion, a PE ratio of 31.99, a price-to-earnings-growth ratio of 1.40 and a beta of 1.27. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.59 and a quick ratio of 1.16. Option Care Health, Inc. has a one year low of $18.37 and a one year high of $31.08.
Option Care Health (NASDAQ:OPCH – Get Rating) last released its quarterly earnings data on Thursday, April 28th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.04. The company had revenue of $915.78 million during the quarter, compared to analyst estimates of $839.45 million. Option Care Health had a net margin of 4.81% and a return on equity of 12.53%. Option Care Health’s revenue for the quarter was up 20.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.02) EPS. Research analysts expect that Option Care Health, Inc. will post 0.89 earnings per share for the current fiscal year.
Several equities research analysts recently commented on OPCH shares. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Option Care Health from $32.00 to $39.00 in a research report on Friday, April 29th. Zacks Investment Research downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Tuesday, May 3rd. TheStreet downgraded shares of Option Care Health from a “b” rating to a “c+” rating in a research report on Thursday, April 28th. Finally, Barrington Research boosted their price target on shares of Option Care Health from $31.00 to $33.00 in a research report on Friday, April 29th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $31.17.
Several large investors have recently added to or reduced their stakes in OPCH. Allspring Global Investments Holdings LLC bought a new stake in shares of Option Care Health in the 4th quarter valued at $96,743,000. Marshall Wace LLP bought a new stake in Option Care Health during the 4th quarter valued at $85,991,000. Venor Capital Management LP bought a new stake in Option Care Health during the 4th quarter valued at $15,601,000. Norges Bank bought a new stake in Option Care Health during the 4th quarter valued at $42,794,000. Finally, JPMorgan Chase & Co. increased its stake in Option Care Health by 172.2% during the 4th quarter. JPMorgan Chase & Co. now owns 2,032,921 shares of the company’s stock valued at $57,816,000 after purchasing an additional 1,285,972 shares in the last quarter. Institutional investors own 98.23% of the company’s stock.
About Option Care Health (Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Receive News & Ratings for Option Care Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Option Care Health and related companies with MarketBeat.com’s FREE daily email newsletter.